Skip to Content Skip to Content

News Archive

Every story published by Penn Today—all in one place.
Reset All Filters
7273 Results
Political leanings dictate feelings about surveillance of low-income populations
Joseph Turow, a researcher in the Annenberg School for Communication at Penn.

Joseph Turow, a researcher in the Annenberg School for Communication at Penn.

Political leanings dictate feelings about surveillance of low-income populations

New research led by Annenberg’s Joseph Turow reveals that political party and orientation matter when it comes to how Americans feel about everyday surveillance of low-income populations.

Michele W. Berger

Healthy T cells have a fighting chance for cell therapy
t-cell

Healthy T cells have a fighting chance for cell therapy

Patients with chronic lymphocytic leukemia (CLL) who have a healthy amount of T cells prior to treatment (“early memory” T cells) responded positively to CAR T therapy, highlighting a powerful biomarker for successful therapies for that specific type of leukemia. 

Penn Today Staff

A reading and discussion with Charles Blow, following a deep dive into his work
New York Times columnist Charles Blow and Penn Professor Al Filreis at Kelly Writers House.

New York Times columnist and author Charles Blow (left) speaks with Penn English Professor Al Filreis at the Kelly Writers House. 

A reading and discussion with Charles Blow, following a deep dive into his work

For their class at Kelly Writers House, Penn students read 82 columns and a personal memoir written by Charles Blow, an opinion writer at The New York Times.
A potential new weapon in the battle against addiction
Research from Penn’s Heath Schmidt revealed that drugs already approved by the FDA to treat diabetes and obesity may reduce cocaine relapse and help addicted people break the habit

The green fluorescent ‘dots’ above show where Exendin-4, an FDA-approved drug used to treat diabetes and obesity, ends up in the brain. The drug activates receptors for glucagon-like peptide 1 or GLP-1, a hormone that reduces food intake. The blue and red coloring indicate neurons and astrocytes, respectively.

A potential new weapon in the battle against addiction

New research revealed that FDA-approved drugs to treat diabetes and obesity may reduce cocaine relapse and help addicts break the habit. Such medications work by targeting receptors for glucagon-like peptide 1, a hormone in the brain.

Michele W. Berger

A Relays recap
Penn Relays 2018

A Relays recap

The 124th running of the Penn Relays featured athletes from more than 200 colleges, 1,000 high schools, and professionals competing in the three-day festival.